Cancer Research U.K. Viral Oncology Group, Wolfson Institute for Biomedical Research, University College London, London, UK c.boshoff@ucl.ac.uk
Kaposi sarcoma herpesvirus (KSHV) seems to exploit almost every known cancer pathway to promote tumorigenesis. Activation of the canonical Wnt−-catenin pathway can now be added to its list of conquests (pages 300−306).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
-catenin pathway can now be added to its list of conquests (pages 300−306).
-catenin in Kaposi's sarcoma–associated herpesvirus latency
